KMT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KMT is not a good buy right now for a Beginner investor with a long-term horizon and $50,000-$100,000 to deploy. The stock has lost momentum after a recent downgrade, technicals are weak, and there is no strong proprietary buy signal. I would not buy it at this moment; the clearer decision is to hold off and wait for a stronger setup.
The current pre-market price is 33.63, essentially flat, but the technical picture is bearish to weak. MACD histogram is -0.187 and negatively expanding, which points to weakening momentum. RSI_6 at 33.2 is near oversold but not yet a clear reversal signal. Moving averages are converging, suggesting indecision rather than a confirmed uptrend. Price is sitting just below/near S1 at 33.688, with downside support at S2 near 32.796 and upside resistance at 35.132 pivot, then 36.576 and 37.468. The near-term trend data also points lower over the next day, week, and month.
["The company completed a cash tender offer, acquiring $209.384 million of its 4.625% senior notes, which supports debt management and may improve financial flexibility.", "Price is near support levels, which could attract value buyers if momentum stabilizes.", "RSI is near oversold territory, leaving room for a bounce if selling pressure eases."]
["Barclays downgraded Kennametal to Underweight and cut its price target to $33, citing fading tungsten tailwinds and elevated valuation.", "Jefferies downgraded the stock to Hold, saying risk/reward is now more balanced after a large year-to-date run.", "Goldman Sachs keeps a Sell rating, reinforcing a cautious Wall Street tone.", "Technical momentum is weak with a negative and expanding MACD histogram.", "Options flow is slightly bearish with put interest and put volume both above calls.", "Historical pattern data suggests negative short-term performance probabilities.", "No meaningful insider or hedge fund accumulation trend is present."]
No latest-quarter financial snapshot was available in the provided data, so I cannot verify quarterly revenue or earnings growth directly. The only financial-related update is the debt tender offer, which is a constructive balance-sheet move but does not substitute for operating growth. The news flow suggests investors are now focusing more on non-tungsten earnings, implying that recent upside from tungsten may be fading.
Analyst sentiment has turned more cautious. Barclays downgraded KMT to Underweight and lowered its target to $33 from $40. Jefferies also downgraded the stock to Hold from Buy, and Goldman Sachs remains at Sell. JPMorgan raised its target to $40 but kept Underweight. Overall, Wall Street pros view the stock as fairly to richly valued after its run, with limited upside unless non-tungsten earnings improve more than expected.
